Fayez Sarofim & CO Merck & Co., Inc. Transaction History
Fayez Sarofim & CO
- $39.8 Billion
- Q4 2024
A detailed history of Fayez Sarofim & CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fayez Sarofim & CO holds 3,204,907 shares of MRK stock, worth $304 Million. This represents 0.8% of its overall portfolio holdings.
Number of Shares
3,204,907
Previous 2,895,191
10.7%
Holding current value
$304 Million
Previous $329 Million
3.03%
% of portfolio
0.8%
Previous 0.85%
Shares
30 transactions
Others Institutions Holding MRK
# of Institutions
3,969Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$23.8 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$11.5 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.65 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.79 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $240B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...